The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma

被引:73
作者
Wang, Wentao [1 ,2 ]
Guo, Yaxun [1 ,2 ]
Zhong, Jingtao [3 ]
Wang, Qi [1 ]
Wang, Xin [1 ,2 ]
Wei, Honglong [1 ,2 ]
Li, Jie [1 ,2 ]
Xiu, Peng [1 ,2 ]
机构
[1] Shandong Univ, Shandong Qianfoshan Hosp, Cheeloo Coll Med, Dept Gen Surg, Jinan 250014, Shandong, Peoples R China
[2] Shandong First Med Univ, Hosp 1, Shandong Prov Qianfoshan Hosp, Dept Gen Surg, Jinan, Peoples R China
[3] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Hepatobiliary Surg, Jinan, Peoples R China
关键词
ADJUVANT TRANSARTERIAL CHEMOEMBOLIZATION; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CURATIVE RESECTION; GROSS CLASSIFICATION; LIVER RESECTION; RECURRENCE; SORAFENIB; RISK; SURVIVAL; PREDICT;
D O I
10.1038/s41598-021-82058-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hepatocellular carcinoma (HCC) is one of the most common and most lethal malignant tumors in the world. Microvascular invasion (MVI) is a major risk factor for survival outcomes and intrahepatic metastasis after resection in patients with HCC. Relevant English literatures retrieved using PubMed on the research progress of MVI in patients with HCC were reviewed. For HCC patients, especially those with MVI, it is very important to develop a comprehensive and sequential treatment plan to support the long-term survival of patients. This manuscript reviewed and analyzed the risk factors for MVI; the preoperative prediction of MVI, which informs the selection of surgical strategies; and the current situation and future direction of comprehensive postoperative treatment strategies; to provide a basis for the comprehensive treatment of HCC patients with MVI. For HCC patients with MVI, the preoperative prediction of MVI may play a certain guiding role in planning procedures, and the comprehensive sequential postoperative pathological detection of HCC MVI may provide a basis for treatment decisions.
引用
收藏
页数:10
相关论文
共 83 条
[1]  
[Anonymous], 2015, Zhonghua Gan Zang Bing Za Zhi, V23, P321
[2]   A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma [J].
Ariizumi, Shun-ichi ;
Kitagawa, Koichi ;
Kotera, Yoshihito ;
Takahashi, Yutaka ;
Katagiri, Satoshi ;
Kuwatsuru, Ryohei ;
Yamamoto, Masakazu .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2011, 18 (04) :575-585
[3]   Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Bruix, Jordi ;
Qin, Shukui ;
Merle, Philippe ;
Granito, Alessandro ;
Huang, Yi-Hsiang ;
Bodoky, Gyrogy ;
Pracht, Marc ;
Yokosuka, Osamu ;
Rosmorduc, Olivier ;
Breder, Valeriy ;
Gerolami, Rene ;
Masi, Gianluca ;
Ross, Paul J. ;
Song, Tianqiang ;
Bronowicki, Jean-Pierre ;
Ollivier-Hourmand, Isabelle ;
Kudo, Masatoshi ;
Cheng, Ann-Lii ;
Llovet, Josep M. ;
Finn, Richard S. ;
LeBerre, Marie-Aude ;
Baumhauer, Annette ;
Meinhardt, Gerold ;
Han, Guohong .
LANCET, 2017, 389 (10064) :56-66
[4]   Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma [J].
Chen, Liping ;
Zhang, Qi ;
Chang, Wenjun ;
Du, Yan ;
Zhang, Hongwei ;
Cao, Guangwen .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (13) :1977-1987
[5]   Cancer incidence and mortality in China, 2014 [J].
Chen, Wanqing ;
Sun, Kexin ;
Zheng, Rongshou ;
Zeng, Hongmei ;
Zhang, Siwei ;
Xia, Changfa ;
Yang, Zhixun ;
Li, He ;
Zou, Xiaonong ;
He, Jie .
CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (01) :1-12
[6]   Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis [J].
Chen, Zhen-Hua ;
Zhang, Xiu-Ping ;
Zhou, Teng-Fei ;
Wang, Kang ;
Wang, Hang ;
Chai, Zong-Tao ;
Shi, Jie ;
Guo, Wei-Xing ;
Cheng, Shu-Qun .
EJSO, 2019, 45 (11) :2188-2196
[7]   Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].
Cheng, Ann-Lii ;
Kang, Yoon-Koo ;
Chen, Zhendong ;
Tsao, Chao-Jung ;
Qin, Shukui ;
Kim, Jun Suk ;
Luo, Rongcheng ;
Feng, Jifeng ;
Ye, Shenglong ;
Yang, Tsai-Sheng ;
Xu, Jianming ;
Sun, Yan ;
Liang, Houjie ;
Liu, Jiwei ;
Wang, Jiejun ;
Tak, Won Young ;
Pan, Hongming ;
Burock, Karin ;
Zou, Jessie ;
Voliotis, Dimitris ;
Guan, Zhongzhen .
LANCET ONCOLOGY, 2009, 10 (01) :25-34
[8]   MRI Features of Hepatocellular Carcinoma Related to Biologic Behavior [J].
Cho, Eun-Suk ;
Choi, Jin-Young .
KOREAN JOURNAL OF RADIOLOGY, 2015, 16 (03) :449-464
[9]   Prediction of Microvascular Invasion of Hepatocellular Carcinoma: Preoperative CT and Histopathologic Correlation [J].
Chou, Chen-Te ;
Chen, Ran-Chou ;
Lin, Wei-Chan ;
Ko, Chih-Jan ;
Chen, Chia-Bang ;
Chen, Yao-Li .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2014, 203 (03) :W253-W259
[10]   Predictor for Histological Microvascular Invasion of Hepatocellular Carcinoma: A Lesson from 229 Consecutive Cases of Curative Liver Resection [J].
Eguchi, Susumu ;
Takatsuki, Mitsuhisa ;
Hidaka, Masaaki ;
Soyama, Akihiko ;
Tomonaga, Tetsuo ;
Muraoka, Izumi ;
Kanematsu, Takashi .
WORLD JOURNAL OF SURGERY, 2010, 34 (05) :1034-1038